CClinicalTrials.gg
Enrolling by invitationNCT07663240Updated Jun 23, 2026

Epilepsy Emergency Department High Utilizer Program

An observational study in Epilepsy and Uncontrolled Seizures, sponsored by Morehouse School of Medicine. Enrolling by invitation at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-23.

Sponsored by Morehouse School of Medicine · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
15
Ages
18 Years and older
Sex
Female
01

Study summary

We believe that there are many reasons that people with epilepsy get their health care through the emergency department (ED) instead of through primary care or neurology. Our goal is to create program that will address these reasons. The creation of this program will be informed by use of the Grady electronic health records (EHR). We will use the EHR to describe people with epilepsy coming the Grady ED at a high frequency. We create a profile of these patients by examining their demographics and social determinants of health information in their EHR (Aim 1). We will then use that information to create a culturally and medically appropriate program for people with epilepsy (Aim 2). Next, we will test the new program, the Epilepsy Emergency Department High Utilizer Program (Aim 3). We believe this program may improve three things. It will first improve access to care by epilepsy and mental health doctors, and reduce ED visits. It may also help people to manage their triggers, track seizures, and take their medicines on time. And last, we believe it may improve seizure frequency and quality of life for people that are underserved in health care. With the lessons learned from the new program, we will explore ways to sustain the program at Grady and expand it to other health care facilities (Aim 4).

02

Conditions studied

  • Epilepsy
  • Uncontrolled Seizures

Browse trials for

Keywords

  • Epilepsy
  • Uncontrolled seizured
  • Frequent ED use
  • High utilizers
  • Community Health Worker
  • Care coordination
  • African American / Black
  • Underserved populations
  • Social determinants of health
  • Multidisciplinary care
  • Integrated care
  • Transitions of Care Program
03

In context

Epilepsy

1,805 studies on the registry are indexed under Epilepsy; 417 are open to participants now.

This study's planned enrollment of 15 is below the median of 102 across 521 observational studies indexed under Epilepsy.

Browse Epilepsy studies →

Lead sponsor

Morehouse School of Medicine is the lead sponsor of 22 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population includes adult women with a confirmed diagnosis of epilepsy who are high utilizers of emergency department services at Grady Health System. Participants are enrolled through the Transition of Care (TOC) ED High Utilizer Program and have a history of frequent seizure-related ED visits. The study focuses on Black and Hispanic women residing in the Atlanta metropolitan area.

Inclusion criteria

  • Adult women aged 18 years or older
  • Confirmed diagnosis of epilepsy documented in the electronic health record (EHR)
  • Enrolled in the Grady Health System Transition of Care (TOC) ED High Utilizer Program
  • History of three or more seizure-related emergency department visits within the past 12 months
  • Self-identify as Black or Hispanic
  • Reside in the Atlanta metropolitan area with intent to remain for at least 12 months
  • Have access to a working phone for follow-up communication

Exclusion criteria

Exclusion Criteria:

  • No confirmed epilepsy diagnosis (e.g., non-epileptic seizures)
  • Younger than 18 years of age
  • Not identified as a high ED utilizer for seizure-related care
  • Unable to provide informed consent due to cognitive impairment or psychiatric instability
  • Regularly taking anti-epileptic medications with established adherence
  • Scheduled neurology follow-up within 14 days of discharge or consistent primary care follow-up
  • Complex medical conditions that would limit participation in outpatient follow-up
  • Non-English speaking
  • Pregnant
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
15 participants (estimated)
Patient registry
No

Groups and cohorts

  • CHW-Led Transition-of-Care Intervention

    This study evaluates a community health worker (CHW)-led transition-of-care intervention for adults with epilepsy who are high utilizers of emergency department services. Participants are enrolled following identification through the Grady Health System Transition of Care (TOC) ED High Utilizer Program. Participants receive ongoing support from a trained CHW over a 9-12 month period. The intervention includes regular home visits and phone follow-up to support epilepsy self-management, including education on seizure recognition, medication adherence, identification of seizure triggers, and reinforcement of treatment plans. The CHW provides care coordination by assisting with appointment scheduling, facilitating communication with healthcare providers, and supporting linkage to neurology, primary care, behavioral health, and community-based services. The intervention also addresses social determinants of health, including transportation, housing, and access to resources that may impac

    Behavioral: CHW-Led Transition-of-Care Intervention

Interventions

  • BehavioralCHW-Led Transition-of-Care Intervention

    Participants receive a community health worker (CHW)-led transition-of-care intervention for adults with epilepsy who frequently use emergency department services. Over 9-12 months, the CHW provides home visits and phone follow-up to support seizure self-management, medication adherence, and care coordination. The CHW assists with appointment scheduling, connects participants to healthcare and community resources, and addresses social needs such as transportation and access to care. The goal is to improve continuity of care and reduce emergency department utilization.

06

What researchers measure

Primary outcomes

  1. Emergency Department Utilization

    Reduced emergency department visits

    Time frame: Baseline to 9-12 months post-enrollment

07

Study locations

1 site
  • Morehouse School of Medicine
    Atlanta, Georgia 30310, United States
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data will include demographic characteristics, clinical variables (e.g., seizure frequency, emergency department utilization, medication adherence), and participant-reported outcomes related to epilepsy self-management, quality of life, and behavioral health measures collected during the study period.

Supporting information: Study protocol, Sap, Icf

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07663240
Lead sponsor
Morehouse School of Medicine
Collaborators
Grady Health System, Emory University, UCB Pharma, Epilepsy Foundation, NYU Langone Health
Responsible party
Sponsor
First posted
Jun 23, 2026
Start date
May 1, 2026
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jun 23, 2026

Study contacts

Rakale Quarells, PhD
principal investigator · Morehouse School of Medicine

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion